28Oct 2022
Optimal Cardiometabolic Health and Risk of Heart Failure in Type 2 Diabetes: An Analysis from the Look AHEAD Trial

Optimal Cardiometabolic Health and Risk of Heart Failure in Type 2 Diabetes: An Analysis from the Look AHEAD Trial

To evaluate the contribution of baseline and longitudinal changes in cardiometabolic health (CMH) towards heart failure (HF) risk among adults with type 2 diabetes (T2D). Participants of the Look AHEAD trial with T2D and without prevalent HF were included. Achieving target levels of more CMH parameters at baseline and sustained improvements were associated with lower HF risk in T2D.

  • #cardiology

Like

Save

Share